Cancer Clinical Trial
Official title:
Evaluating the CAREchart@Home™ Program for Enhancing After-hours Care of Cancer Patients in Ontario: A Pilot Randomized Controlled Trial
Verified date | January 2020 |
Source | Women's College Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of the current project is to pilot the evaluation of the health and economic
benefits of having online access to health information in the context of providing
telemedicine support for oncology patients receiving outpatient systemic therapy in Ontario.
This pilot study will determine the feasibility of conducting a full-scale randomized
controlled trial that could definitively determine whether the addition of access to
patients' health information in the after-hours telemedicine program reduces emergency
department use, affect patients' experience of care, or improve patient-reported health.
The study will be conducted at, and with patients from, the Stronach Regional Cancer Centre
(SRCC) at Southlake. Eligible patients will be adults (at least 18 years of age) with a
confirmed cancer diagnosis, and initiating or continuing treatment with systemic therapy at
the SRCC. Prospective patients will be randomized across two arms. Recruitment will take
place during a 6.5-month recruitment period and followed up for a period of 3 months.
Status | Terminated |
Enrollment | 105 |
Est. completion date | May 9, 2019 |
Est. primary completion date | May 9, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility |
Inclusion Criteria: - Confirmed cancer diagnosis (all cancers, all stages) - Initiating or continuing treatment with systemic therapy (oral or injected/IV; excluding hormonal therapy for breast or prostate cancer) at Stronach Regional Cancer Centre at Southlake Exclusion Criteria: - Being treated with radiation - Unable to read or understand spoken English (Required for completing the questionnaires) - Unable to utilize the after-hours services due to cognitive impairment |
Country | Name | City | State |
---|---|---|---|
Canada | Southlake Regional Health Centre | Newmarket | Ontario |
Lead Sponsor | Collaborator |
---|---|
Women's College Hospital | Southlake Regional Health Centre |
Canada,
Barbera L, Atzema C, Sutradhar R, Seow H, Howell D, Husain A, Sussman J, Earle C, Liu Y, Dudgeon D. Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Ann Emerg Med. 2013 Apr;61(4):427-437.e5. doi: 10.1016/j.annemergmed.2012.10.010. Epub 2013 Jan 4. — View Citation
Cancer Care Ontario. (2014). Quality Person-Centred Systemic Treatment in Ontario, 2014-2019 (pp. 1-46). Toronto, ON: Cancer Care Ontario.
Cancer Quality Council of Ontario. (2016, October). Cancer Safety Quality Index: Unplanned Hospital Visits During Chemotherapy. Retrieved March 23, 2018, from http://www.csqi.on.ca/by_patient_journey/treatment/unplanned_hospital_visits_during_chemotherapy/
Ferrer-Roca O, Subirana R. A four-year study of telephone support for oncology patients using a non-supervised call centre. J Telemed Telecare. 2002;8(6):331-6. — View Citation
Kurtz ME, Kurtz JC, Given CW, Given B. Effects of a symptom control intervention on utilization of health care services among cancer patients. Med Sci Monit. 2006 Jul;12(7):CR319-24. Epub 2006 Jun 28. — View Citation
Palumbo MO, Kavan P, Miller WH Jr, Panasci L, Assouline S, Johnson N, Cohen V, Patenaude F, Pollak M, Jagoe RT, Batist G. Systemic cancer therapy: achievements and challenges that lie ahead. Front Pharmacol. 2013 May 7;4:57. doi: 10.3389/fphar.2013.00057. eCollection 2013. — View Citation
Panattoni, L., Fedorenko, C. R., Kreizenbeck, K. L., Greenlee, S., Walker, J. R., Greenwood-Hickman, M. A., et al. (2017). Costs of potentially preventable emergency department use during cancer treatment: A regional study [Abstract]. Journal of Clinical Oncology / 2017 ASCO Annual Meeting, 35(8_suppl), Abst 6505. http://doi.org/10.1200/JCO.2017.35.8_suppl.2
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of patients willing to be randomized | The proportion of patients willing to be randomized | 9.5 Months | |
Primary | Proportion of enrolled patients lost to follow up | The proportion of enrolled patients lost to follow up in each randomized group | 9.5 Months | |
Primary | Number of attempted questionnaires relative to number of questionnaires that should have been completed | The number of completed questionnaires for both patient participants and healthcare provider participants in relation to the total number of times a questionnaire should have been completed | 9.5 Months | |
Primary | Number of completed questionnaires relative to number of questionnaires that should have been completed | The number of attempted questionnaires for both patient participants and healthcare provider participants in relation to the total number of times a questionnaire should have been completed | 9.5 Months | |
Primary | Percent of total emergency department (ED) visits reported that occurred at Southlake | Comparison of total self-reported ED visits to total ED visits recorded in institutional records | 9.5 Months | |
Primary | Time to complete questionnaire battery | Estimation of time required for patients to complete the questionnaires at each timepoint | 9.5 Months | |
Primary | Completion rate for satisfaction survey | Percent of callers for whom Bayshore's satisfaction survey results were obtained | 9.5 Months | |
Secondary | Self-reported health service utilization | Total number of encounters with the health system for any concern, including cancer-related symptom management. | 3 Months | |
Secondary | Hospital-reported health service utilization: Emergency Department Visits | The total number of emergency department visits | 3 Months | |
Secondary | Hospital-reported health service utilization: Outcomes of ED Visits | The outcomes of the emergency department visits | 3 Months | |
Secondary | Hospital-reported health service utilization: Length of Hospital Stay | The total length of stay for any admission to the hospital | 3 Months | |
Secondary | Edmonton Symptom Assessment System-revised (ESAS-r) Scale | Self-reported measurement of the severity of nine common symptoms of cancer, at the time of questionnaire completion | 3 Months | |
Secondary | Functional Assessment of Cancer Therapy - General (FACT-G) Scale | Patient-reported assessment of health-related quality of life, over the past week, for patients undergoing cancer therapy | 3 Months | |
Secondary | Prompt Access to Care (PAC) Scale | Measurement of a cancer patient's perception of their ability to reach or see an oncology professional, as required, at various times of the day and on different days of the week | 3 Months | |
Secondary | Continuity of Care (CoC) Scale | Measurement of a cancer patient's perception of continuity of care across all healthcare professionals in the cancer care continuum | 3 Months | |
Secondary | Prevented health service utilization | Frequency of reports of a health service that a patient would have accessed if they did not have access to the after-hours service | 3 Months | |
Secondary | Efficiency of after-hours service advice | Proportion of calls that were handled by telephone advice alone, that is, those calls that were not followed by any unplanned referrals or visits to other healthcare professional within 2 weeks of the after-hours service encounter | 3 Months | |
Secondary | Patient confidence | Patients' level of confidence in the advice they received through the after-hours service | 3 Months | |
Secondary | Perceived reliability of the after-hours service encounter | Patients' perceived reliability of the after-hours service encounter which will be measured as agreement with a statement regarding the similarity of the encounter to an in-person visit | 3 Months | |
Secondary | Provider confidence (measured using a modified version of the C-scale) | Assessment of a nurse's confidence in relation to various aspects of the triage encounter | 3 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|